CHRISTINE GILMORE: Open Payments
NPI 1851686356 · BEDFORD, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$34,461 in 117 payments from 9 companies in 2025. Trend: 2023 $18,338 · 2024 $21,889 · 2025 $34,461
Speaker / faculty: $25,198Consulting: $6,330Food & beverage: $2,284Travel & lodging: $548Education: $101
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 37 | $25,307 |
| Teva Pharmaceuticals USA, Inc. | 20 | $7,974 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $256 |
| Janssen Pharmaceuticals, Inc | 9 | $249 |
| Otsuka America Pharmaceutical, Inc. | 15 | $231 |
| E.R. Squibb & Sons, L.L.C. | 3 | $159 |
| Alkermes, Inc. | 11 | $148 |
| Lundbeck LLC | 6 | $105 |
| ABBVIE INC. | 2 | $31 |
Products named: INGREZZA, AUSTEDO XR, CAPLYTA, INVEGA SUSTENNA, UZEDY, COBENFY, ARISTADA, ABILIFY MAINTENA.
Industry payments across VA — which companies pay providers there.
